While different individual HIV neurocognitive studies have specific selection criteria, especially related to HIV viral load and antiretroviral therapy, inclusion criteria for this overarching protocol will be flexible in order to identify the broadest base of potential enrollees possible. An upper age limit of 61 years old will be used because changes in neurocognitive function occur more commonly in the general population after this age.